骨髓增殖性新生体:当代审查和分子景观
Muftah Mahmud1, Swati Vasireddy2, Krisstina Gowin3
1Department of Medicine, Midwestern University Internal Medicine Residency Consortium, Cottonwood, AZ 86326, USA.
International journal of molecular sciences
|December 23, 2023
概括
骨髓纤维化 (MF),骨髓增殖性新生体 (MPN) 和MDS/MPN重叠综合征涉及复杂的分子和临床特征. 尽管药理疗法取得了进展,但先进的治疗方法主要集中在造血干细胞移植上.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
背景情况:
- 骨髓纤维化 (MF),骨髓增殖性新生体 (MPN) 和MDS/MPN重叠综合征具有不同的临床和分子特征.
- 由于这种异质性,诊断和分类具有挑战性.
研究的目的:
- 审查这些骨髓性恶性瘤中的分子异常,表观遗传修饰和染色体异常.
- 探索它们与细胞和免疫机制的相互作用.
- 讨论临床特征,分类和治疗策略.
主要方法:
- 文献综述专注于分子遗传学和免疫学.
- 对新一代测序研究数据的分析.
- 综合有关疾病表现和治疗方法的信息.
主要成果:
- 新一代测序显著提高了对MF,MPN和MDS/MPN重叠综合征的遗传因素的理解.
- 分子异常和免疫机制之间的相互作用影响疾病的呈现.
- 药理疗法得到了改进,但造血干细胞移植仍然是高级阶段的关键.
结论:
- 对分子和免疫学因素的全面理解对于管理这些复杂的髓状细胞疾病至关重要.
- 虽然有针对性的疗法正在发展,但造血干细胞移植是晚期疾病的最终治疗方法.
相关概念视频
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K


